Annual report
4465.TEDINET S100WL0G
Period2024-06-01 → 2025-05-31
Filed2025-08-26
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.7bn | 2024-06-01 → 2025-05-31 | Cons. | Net sales |
| Revenue | ¥22.7bn | 2023-06-01 → 2024-05-31 | Cons. | Net sales |
| Revenue | ¥19.5bn | 2022-06-01 → 2023-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥17.8bn | 2021-06-01 → 2022-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.4bn | 2020-06-01 → 2021-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.9bn | 2024-06-01 → 2025-05-31 | Cons. | Operating income |
| Operating income | ¥1.5bn | 2023-06-01 → 2024-05-31 | Cons. | Operating income |
| Ordinary income | ¥2.0bn | 2024-06-01 → 2025-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2023-06-01 → 2024-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥887m | 2022-06-01 → 2023-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2021-06-01 → 2022-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.5bn | 2020-06-01 → 2021-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.6bn | 2024-06-01 → 2025-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥812m | 2023-06-01 → 2024-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2024-06-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥706m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥562m | 2022-06-01 → 2023-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.2bn | 2021-06-01 → 2022-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥697m | 2020-06-01 → 2021-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.8bn | 2024-06-01 → 2025-05-31 | Cons. | Profit loss |
| Net income | ¥716m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss |
| Total assets | ¥22.6bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥22.7bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥23.6bn | at 2023-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.8bn | at 2022-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.5bn | at 2021-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.8bn | at 2025-05-31 | Cons. | Liabilities |
| Total liabilities | ¥9.4bn | at 2024-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥14.8bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥13.4bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2023-05-31v | Cons. | Net assets |
| Net assets / equity | ¥12.5bn | at 2022-05-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥11.3bn | at 2021-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.8bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.0bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.5bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2023-05-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.1bn | at 2022-05-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥5.8bn | at 2021-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.0bn | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.6bn | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥420m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥102m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥690m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥616m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥946m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.4bn | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥92m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥789m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.7bn | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥305.84 | 2024-06-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥119.58 | 2023-06-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.13 | 2022-06-01 → 2023-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥208.59 | 2021-06-01 → 2022-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥118.11 | 2020-06-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,499.68 | at 2025-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,267.35 | at 2024-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,179.33 | at 2023-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,121.49 | at 2022-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,912.9 | at 2021-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 65.3% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2023-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.2% | at 2022-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.2% | at 2021-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.8% | 2024-06-01 → 2025-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2023-06-01 → 2024-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.4% | 2022-06-01 → 2023-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2021-06-01 → 2022-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2020-06-01 → 2021-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 400 | at 2025-05-31 | Cons. | Number of employees |
| Employees | 394 | at 2024-05-31 | Cons. | Number of employees |
| Employees | 394 | at 2023-05-31v | Cons. | Number of employees |
| Employees | 339 | at 2022-05-31v | Cons. | Number of employees |
| Employees | 344 | at 2021-05-31d | Cons. | Number of employees |
| Revenue | ¥19.9bn | 2024-06-01 → 2025-05-31 | Standalone | Net sales |
| Revenue | ¥19.1bn | 2023-06-01 → 2024-05-31 | Standalone | Net sales |
| Revenue | ¥18.4bn | 2022-06-01 → 2023-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.9bn | 2021-06-01 → 2022-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥17.0bn | 2020-06-01 → 2021-05-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.6bn | 2024-06-01 → 2025-05-31 | Standalone | Operating income |
| Operating income | ¥1.2bn | 2023-06-01 → 2024-05-31 | Standalone | Operating income |
| Ordinary income | ¥1.7bn | 2024-06-01 → 2025-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.2bn | 2023-06-01 → 2024-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.0bn | 2022-06-01 → 2023-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2021-06-01 → 2022-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2020-06-01 → 2021-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.0bn | 2024-06-01 → 2025-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥754m | 2023-06-01 → 2024-05-31 | Standalone | Income before income taxes |
| Net income | ¥1.3bn | 2024-06-01 → 2025-05-31 | Standalone | Profit loss |
| Net income | ¥788m | 2023-06-01 → 2024-05-31 | Standalone | Profit loss |
| Net income | ¥715m | 2022-06-01 → 2023-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.2bn | 2021-06-01 → 2022-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥716m | 2020-06-01 → 2021-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥20.5bn | at 2025-05-31 | Standalone | Assets |
| Total assets | ¥20.7bn | at 2024-05-31 | Standalone | Assets |
| Total assets | ¥20.6bn | at 2023-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥19.6bn | at 2022-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥19.3bn | at 2021-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥6.8bn | at 2025-05-31 | Standalone | Liabilities |
| Total liabilities | ¥7.9bn | at 2024-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥13.7bn | at 2025-05-31 | Standalone | Net assets |
| Net assets / equity | ¥12.7bn | at 2024-05-31 | Standalone | Net assets |
| Net assets / equity | ¥12.2bn | at 2023-05-31v | Standalone | Net assets |
| Net assets / equity | ¥11.7bn | at 2022-05-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥10.7bn | at 2021-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.0bn | at 2025-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.2bn | at 2024-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥226.49 | 2024-06-01 → 2025-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥133.46 | 2023-06-01 → 2024-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥121.18 | 2022-06-01 → 2023-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥198.41 | 2021-06-01 → 2022-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥121.28 | 2020-06-01 → 2021-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥92 | 2024-06-01 → 2025-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥44 | 2023-06-01 → 2024-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥64 | 2022-06-01 → 2023-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2021-06-01 → 2022-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥26 | 2020-06-01 → 2021-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,323.58 | at 2025-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,154.42 | at 2024-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,066.02 | at 2023-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,986.14 | at 2022-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,820.18 | at 2021-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 66.8% | at 2025-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.5% | at 2024-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.2% | at 2023-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.0% | at 2022-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.6% | at 2021-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.1% | 2024-06-01 → 2025-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2023-06-01 → 2024-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2022-06-01 → 2023-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.4% | 2021-06-01 → 2022-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2020-06-01 → 2021-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,943,000 | at 2025-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2024-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2023-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2022-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2021-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 242 | at 2025-05-31 | Standalone | Number of employees |
| Employees | 239 | at 2024-05-31 | Standalone | Number of employees |
| Employees | 239 | at 2023-05-31v | Standalone | Number of employees |
| Employees | 231 | at 2022-05-31v | Standalone | Number of employees |
| Employees | 234 | at 2021-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Chemical Businessreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥442m |
| Chemical Businessreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥497m |
| Chemical Businessreportable segment | employees | at 2025-05-31 | 376 pure |
| Chemical Businessreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥22.2bn |
| Chemical Businessreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥22.2bn |
| Chemical Businessreportable segment | segment assets | at 2025-05-31 | ¥20.7bn |
| Chemical Businessreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥1.6bn |
| Healthcare Businessreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥9m |
| Healthcare Businessreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥36m |
| Healthcare Businessreportable segment | employees | at 2025-05-31 | 24 pure |
| Healthcare Businessreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥1.5bn |
| Healthcare Businessreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥1.5bn |
| Healthcare Businessreportable segment | segment assets | at 2025-05-31 | ¥1.8bn |
| Healthcare Businessreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥278m |
| —segment total | capex | 2024-06-01 → 2025-05-31 | ¥451m |
| —segment total | depreciation | 2024-06-01 → 2025-05-31 | ¥533m |
| —segment total | revenue | 2024-06-01 → 2025-05-31 | ¥23.7bn |
| —segment total | revenue external | 2024-06-01 → 2025-05-31 | ¥23.7bn |
| —segment total | segment assets | at 2025-05-31 | ¥22.6bn |
| —segment total | segment profit | 2024-06-01 → 2025-05-31 | ¥1.9bn |
| Chemical Businessreportable segment | capex | 2023-06-01 → 2024-05-31 | ¥175m |
| Chemical Businessreportable segment | depreciation | 2023-06-01 → 2024-05-31 | ¥509m |
| Chemical Businessreportable segment | revenue | 2023-06-01 → 2024-05-31 | ¥21.3bn |
| Chemical Businessreportable segment | revenue external | 2023-06-01 → 2024-05-31 | ¥21.3bn |
| Chemical Businessreportable segment | segment assets | at 2024-05-31 | ¥21.1bn |
| Chemical Businessreportable segment | segment profit | 2023-06-01 → 2024-05-31 | ¥1.2bn |
| Healthcare Businessreportable segment | capex | 2023-06-01 → 2024-05-31 | ¥4m |
| Healthcare Businessreportable segment | depreciation | 2023-06-01 → 2024-05-31 | ¥39m |
| Healthcare Businessreportable segment | revenue | 2023-06-01 → 2024-05-31 | ¥1.5bn |
| Healthcare Businessreportable segment | revenue external | 2023-06-01 → 2024-05-31 | ¥1.5bn |
| Healthcare Businessreportable segment | segment assets | at 2024-05-31 | ¥1.7bn |
| Healthcare Businessreportable segment | segment profit | 2023-06-01 → 2024-05-31 | ¥245m |
| —segment total | capex | 2023-06-01 → 2024-05-31 | ¥179m |
| —segment total | depreciation | 2023-06-01 → 2024-05-31 | ¥549m |
| —segment total | revenue | 2023-06-01 → 2024-05-31 | ¥22.7bn |
| —segment total | revenue external | 2023-06-01 → 2024-05-31 | ¥22.7bn |
| —segment total | segment assets | at 2024-05-31 | ¥22.7bn |
| —segment total | segment profit | 2023-06-01 → 2024-05-31 | ¥1.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,577
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | RecordDateInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | RecordDateInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | RecordDateInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | RecordDateInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 39600 | |
| Number of shares issued shares voting rights | RecordDateInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 5890800 | |
| Number of voting rights issued shares voting rights | RecordDateInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 58908 | |
| Number of shares issued shares voting rights | RecordDateInstant_OrdinarySharesSharesLessThanOneUnitMember | 12652 | |
| Number of shares issued shares voting rights | RecordDateInstant | 5943052 | |
| Number of voting rights issued shares voting rights | RecordDateInstant | 58908 | |
| Number of shares held in own name treasury shares etc | RecordDateInstant_Row1Member | 39600 | |
| Number of shares held in others names treasury shares etc | RecordDateInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | RecordDateInstant_Row1Member | 39600 | |
| Shareholding ratio treasury shares etc | RecordDateInstant_Row1Member | 0.0067 | |
| Number of shares held in own name treasury shares etc | RecordDateInstant | 39600 | |
| Number of shares held in others names treasury shares etc | RecordDateInstant | － | |
| Total number of shares held treasury shares etc | RecordDateInstant | 39600 | |
| Shareholding ratio treasury shares etc | RecordDateInstant | 0.0067 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 236137000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 40.0 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 306978000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 52.0 | |
| Number of male directors and other officers | FilingDateInstant | 6 | |
| Number of female directors and other officers | FilingDateInstant | 2 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.250 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000OkuyamaYoshiakiMember | 70000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000NojiriDaisukeMember | 14000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000SakoHaruhikoMember | 6000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000TakaseKazuhisaMember | 2000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000OkaKazukiMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000MogiTeppeiMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000ShimizuHirokoMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000YamamotoAtsumiMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 97000 | |
| Number of male directors and other officers proposal | FilingDateInstant | 6 | |
| Number of female directors and other officers proposal | FilingDateInstant | 2 | |
| Ratio of female directors and other officers proposal | FilingDateInstant | 0.250 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000OkuyamaYoshiakiMember | 70000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000NojiriDaisukeMember | 14000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000SakoHaruhikoMember | 6000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000TakaseKazuhisaMember | 2000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000OkaKazukiMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000ShimizuHirokoMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000YamamotoAtsumiMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000UedaZyunMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant | 96000 | |
| Audit fees reporting company | Prior1YearDuration | 30000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 28000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 23 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | partial |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |